The 10-for-1 split rumor remains unverified. No ASML management has confirmed a specific ratio or timeline. One headline from moomoo dated July 4, 2026, mentions "ASML Holding NV ADRhedged TM To Carry Out 10-for-1 Stock Split," but this appears to be a misinterpretation or a reference to a related hedged instrument, not an official company announcement . No Reuters, CNBC, or ASML press release confirms any approved split.

The next major catalyst where management could address the topic is the upcoming Q2 2026 earnings report, due in mid-July. Several analysts and media outlets have explicitly noted that investors should watch the next earnings call for any hint of a split .

A Strong Q1 2026 and Raised Guidance

ASML's financial performance provides a solid foundation for the bullish case. The company reported a very strong first quarter in 2026:

• Net sales: €8.8 billion, up 13% year-over-year .
• Gross margin: 53.0% .
• Net income: €2.8 billion .
• Earnings per share (EPS): €7.15 .

Management responded to the strength by raising its full-year 2026 revenue guidance to between €36 billion and €40 billion, up from the prior range of €34 billion to €39 billion . The company also issued Q2 2026 guidance of €8.4 billion to €9.0 billion in net sales with a gross margin between 51% and 52% .

Despite the solid beat and raised outlook, the stock actually fell 6% on the day of the Q1 earnings release. Analysts attributed the decline to the good news already being priced in and simultaneous headlines about new China export restrictions .

The EUV Monopoly and AI-Driven Demand

ASML's core competitive advantage is its near-monopoly on extreme ultraviolet (EUV) lithography machines. These tools are essential for manufacturing the most advanced AI chips used by Nvidia, AMD, TSMC, and Intel. The company carries an unprecedented backlog of approximately $45 billion .

AI chip demand continues to be the dominant growth engine. In a notable development, Intel announced in June 2026 that its 18A-P process node had entered risk production, which directly validated the demand pipeline for ASML's EUV tools and sent the stock to a fresh 52-week high of $1,923 .

Analyst Sentiment: Optimism with a Valuation Caveat

Wall Street remains largely bullish:

• Bank of America reaffirmed a Buy rating in June 2026 and raised its price target to $2,345, citing surging orders for advanced memory and logic chips .
• The consensus Street mean target sits around $1,644, though some analysts see upside to $2,000 or more .
• Morningstar rates ASML at 19% above its fair value estimate, suggesting the stock is overvalued on a fundamental basis at current levels .

The valuation concern is significant. The stock trades at a trailing price-to-earnings (P/E) ratio of roughly 62x, which is elevated by historical standards and leaves very little room for error . The stock has already surged 120% over the trailing 12 months, meaning much of the good news may already be priced in .

The Biggest Downside Risk: China Export Restrictions

Geopolitical risk remains the most significant headwind. The proposed MATCH Act, a bipartisan US bill, would ban exports of ASML's older DUV lithography machines to China — equipment that the company has still been allowed to sell even as its more advanced EUV machines have been restricted since 2019 . The bill specifically names ASML in its text .

China accounted for 36% of ASML's sales in Q4 2025, but the company has already guided investors to expect that figure to compress to roughly 20% in 2026 under current restrictions . The MATCH Act could push that figure even lower. The stock dropped sharply in April and May 2026 on each new China export-control headline .

Broader geopolitical tensions — US-China tech decoupling and potential pressure from the Dutch government — remain a persistent overhang that periodically triggers broad semiconductor sell-offs .

The Balanced Investment Outlook

Bullish factors:

• EUV monopoly with a $45 billion backlog and surging AI-driven orders
• Raised 2026 guidance and a strong Q1 2026 earnings beat
• Multiple analyst upgrades (Bank of America, Bernstein) with price targets above $1,900
• A stock split, if announced, could boost retail interest and liquidity

Bearish factors:

• Trailing P/E of 62x leaves little room for error
• China export restrictions (the MATCH Act) threaten up to 20% of revenue
• The stock is already up 120% over 12 months; much of the good news may be priced in
• Q2 guidance implies a sequential revenue dip from Q1's €8.8 billion
• Geopolitical headlines cause sharp periodic sell-offs

Bottom line: ASML's split speculation is driven by real nominal price mechanics, a peer precedent (KLA), and the approaching Q2 earnings catalyst — but no official 10-for-1 plan exists. The fundamental outlook is strongly positive due to AI-driven EUV demand and a massive backlog, but China export risk and a rich valuation make the risk/reward profile finely balanced in the near term.

The 10-for-1 split rumor remains unverified. No ASML management has confirmed a specific ratio or timeline. One headline from moomoo dated July 4, 2026, mentions "ASML Holding NV ADRhedged TM To Carry Out 10-for-1 Stock Split," but this appears to be a misinterpretation or a reference to a related hedged instrument, not an official company announcement . No Reuters, CNBC, or ASML press release confirms any approved split.

The next major catalyst where management could address the topic is the upcoming Q2 2026 earnings report, due in mid-July. Several analysts and media outlets have explicitly noted that investors should watch the next earnings call for any hint of a split .

A Strong Q1 2026 and Raised Guidance

ASML's financial performance provides a solid foundation for the bullish case. The company reported a very strong first quarter in 2026:

• Net sales: €8.8 billion, up 13% year-over-year .
• Gross margin: 53.0% .
• Net income: €2.8 billion .
• Earnings per share (EPS): €7.15 .

Management responded to the strength by raising its full-year 2026 revenue guidance to between €36 billion and €40 billion, up from the prior range of €34 billion to €39 billion . The company also issued Q2 2026 guidance of €8.4 billion to €9.0 billion in net sales with a gross margin between 51% and 52% .

Despite the solid beat and raised outlook, the stock actually fell 6% on the day of the Q1 earnings release. Analysts attributed the decline to the good news already being priced in and simultaneous headlines about new China export restrictions .

The EUV Monopoly and AI-Driven Demand

ASML's core competitive advantage is its near-monopoly on extreme ultraviolet (EUV) lithography machines. These tools are essential for manufacturing the most advanced AI chips used by Nvidia, AMD, TSMC, and Intel. The company carries an unprecedented backlog of approximately $45 billion .

AI chip demand continues to be the dominant growth engine. In a notable development, Intel announced in June 2026 that its 18A-P process node had entered risk production, which directly validated the demand pipeline for ASML's EUV tools and sent the stock to a fresh 52-week high of $1,923 .

Analyst Sentiment: Optimism with a Valuation Caveat

Wall Street remains largely bullish:

• Bank of America reaffirmed a Buy rating in June 2026 and raised its price target to $2,345, citing surging orders for advanced memory and logic chips .
• The consensus Street mean target sits around $1,644, though some analysts see upside to $2,000 or more .
• Morningstar rates ASML at 19% above its fair value estimate, suggesting the stock is overvalued on a fundamental basis at current levels .

The valuation concern is significant. The stock trades at a trailing price-to-earnings (P/E) ratio of roughly 62x, which is elevated by historical standards and leaves very little room for error . The stock has already surged 120% over the trailing 12 months, meaning much of the good news may already be priced in .

The Biggest Downside Risk: China Export Restrictions

Geopolitical risk remains the most significant headwind. The proposed MATCH Act, a bipartisan US bill, would ban exports of ASML's older DUV lithography machines to China — equipment that the company has still been allowed to sell even as its more advanced EUV machines have been restricted since 2019 . The bill specifically names ASML in its text .

China accounted for 36% of ASML's sales in Q4 2025, but the company has already guided investors to expect that figure to compress to roughly 20% in 2026 under current restrictions . The MATCH Act could push that figure even lower. The stock dropped sharply in April and May 2026 on each new China export-control headline .

Broader geopolitical tensions — US-China tech decoupling and potential pressure from the Dutch government — remain a persistent overhang that periodically triggers broad semiconductor sell-offs .

The Balanced Investment Outlook

Bullish factors:

• EUV monopoly with a $45 billion backlog and surging AI-driven orders
• Raised 2026 guidance and a strong Q1 2026 earnings beat
• Multiple analyst upgrades (Bank of America, Bernstein) with price targets above $1,900
• A stock split, if announced, could boost retail interest and liquidity

Bearish factors:

• Trailing P/E of 62x leaves little room for error
• China export restrictions (the MATCH Act) threaten up to 20% of revenue
• The stock is already up 120% over 12 months; much of the good news may be priced in
• Q2 guidance implies a sequential revenue dip from Q1's €8.8 billion
• Geopolitical headlines cause sharp periodic sell-offs

Bottom line: ASML's split speculation is driven by real nominal price mechanics, a peer precedent (KLA), and the approaching Q2 earnings catalyst — but no official 10-for-1 plan exists. The fundamental outlook is strongly positive due to AI-driven EUV demand and a massive backlog, but China export risk and a rich valuation make the risk/reward profile finely balanced in the near term.